Zhenyu Song
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Calcium oxalate crystals exacerbate the damage and inflammation of renal tubular epithelial cells by blocking autophagic flux.
Journal: Urolithiasis
Published: January 19, 2026
Salidroside attenuates calcium oxalate-induced renal injury via suppression of PANoptosis.
Journal: Urolithiasis
Published: November 09, 2025
SIRT6 attenuates calcium oxalate Nephrocalcinosis-induced renal inflammation and oxidative injury via activating NRF2 signaling.
Journal: International immunopharmacology
Published: January 03, 2025
MicroRNA-335 inhibits invasion and metastasis of prostate cancer by inhibiting glutamine metabolism pathway.
Journal: The Journal of pharmacology and experimental therapeutics
Published: December 11, 2024
The SIRT6 allosteric activator MDL-800 suppresses calcium oxalate nephrocalcinosis by alleviating inflammatory and renal damage.
Journal: International immunopharmacology
Published: October 23, 2024
IGF1R Enhances Calcium Oxalate Monohydrate-Induced Epithelial-Mesenchymal Transition by Reprogramming Metabolism via the JAK2/STAT3 Signaling.
Journal: International journal of biological sciences
Published: September 27, 2024
Predictive factors of stone-free rate and complications in patients with proximal impacted ureteral stones undergoing percutaneous nephrolithotomy: based on a new scoring standard.
Journal: Urolithiasis
Published: August 26, 2024
Puerarin alleviates apoptosis and inflammation in kidney stone cells via the PI3K/AKT pathway: Network pharmacology and experimental verification.
Journal: Journal of cellular and molecular medicine
Published: July 05, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026